-
Virtual Connection in a Time of Social Distance
Responding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones.
by Marci A. Landsmann
-
Cancer Treatment During a Pandemic
People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.
by William G. Nelson, MD, PhD
-
Testing Cancer Patients for the Coronavirus
Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
by Anna Azvolinsky
-
The Coronavirus Impacts Cancer Clinical Trials
The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.
by Anna Azvolinsky
-
The Coronavirus and Cancer Care
Cancer patients in the U.S. are feeling impacts from the new coronavirus.
by Kate Yandell
Previous |
Cancer Talk
Injection Immunotherapies Get FDA Approval
Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore